Antimicrobial polymers formed by bulk polyaddition
Abstract
Cationic antimicrobial polymers have been synthesized by a bulk addition polymerization of a nucleophilic agent comprising two tertiary amines and an electrophilic agent that comprises two leaving groups and an aromatic ring between the leaving groups. The reaction solvent for the polymerization is chosen to allow precipitation of the cationic polymer at the polymerization temperature, thereby limiting molecular weight. Quaternization and polymerization occur concurrently. The cationic polymers can be highly active against Gram-negative and Gram-positive microbes, and/or fungi. The cationic polymers can also be non-hemolytic and non-cytotoxic at the effective concentration against the microbes.
Claims
exact text as granted — not AI-modified1 . A cationic polymer comprising a cationic repeat unit of formula (C-5):
wherein
each R′ is an independent monovalent radical selected from the group consisting of methyl, ethyl and propyl, and
each X′ is an independent negative-charged counterion.
2 . The cationic polymer of claim 1 , wherein the cationic polymer is a homopolymer.
3 . The cationic polymer of claim 1 , wherein each R′ is methyl.
4 . The cationic polymer of claim 1 , wherein each X′ is chloride.
5 . The cationic polymer of claim 1 , wherein the cationic polymer is an effective antimicrobial agent capable of killing a microbe selected from the group consisting of Staphylococcus aureus ( S. aureus ), Escherichia coli ( E. coli ), Candida albicans ( C. albicans ), Pseudomonas aeruginosa ( P. aeruginosa ), Staphylococcus epidermidis ( S. epidermidis ), Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant Enterococcus (VRE), Acinetobacter baumannii ( A. baumannii ), Klebsiella pneumoniae ( K. pneumoniae ), Cryptococcus neoformans ( C. neoformans ), and yeasts.
6 . The cationic polymer of claim 1 , wherein the cationic polymer is a random copolymer comprising a second cationic repeat unit of formula (C-7):
wherein
atomic centers nitrogen 1 and carbon 2 are labeled,
each X′ is an independent negative-charged counterion,
each R″ is an independent monovalent radical selected from the group consisting of methyl, ethyl and propyl.
7 . The cationic polymer of claim 6 , wherein the cationic polymer comprises the cationic repeat units of formulas (C-5) and (C-7) in a (C-5):(C-7) molar ratio of 90:10 to 50:50.
8 . A method of killing a microbe, comprising contacting the microbe with the cationic polymer of claim 1 .
9 . An antimicrobial composition, comprising the cationic polymer of claim 1 and a second component bound together by non-covalent interactions.
10 . The antimicrobial composition of claim 9 , wherein the second component is water.
11 . The antimicrobial composition of claim 9 , wherein the second component is an antibiotic drug.
12 . The antimicrobial composition of claim 9 , wherein the cationic polymer is a random copolymer comprising a second cationic repeat unit of formula (C-7):
wherein
atomic centers nitrogen 1 and carbon 2 are labeled,
each X′ is an independent negative-charged counterion,
each R″ is an independent monovalent radical selected from the group consisting of methyl, ethyl and propyl.
13 . A cationic polymer, comprising a cationic repeat unit of formula (C-7):
wherein
atomic centers nitrogen 1 and carbon 2 are labeled,
each X′ is an independent negative-charged counterion,
each R″ is an independent monovalent radical selected from the group consisting of methyl, ethyl and propyl.
14 . The cationic polymer of claim 13 , wherein the cationic polymer is a homopolymer.
15 . The cationic polymer of claim 13 , wherein the cationic polymer is a random copolymer comprising a second cationic repeat unit of formula (C-1):
wherein
atomic centers nitrogen 1 and carbon 2 of formula (C-1) are labeled,
each X′ is an independent negative-charged counterion, and
each R′ of (C-1) is an independent monovalent radical selected from the group consisting of methyl, ethyl and propyl.
16 . The cationic polymer of claim 13 , wherein the cationic polymer is a random copolymer comprising a second cationic repeat unit of formula (C-5):
wherein
each R′ of (C-5) is an independent monovalent radical selected from the group consisting of methyl, ethyl and propyl, and
each X′ of (C-5) is an independent negative-charged counterion.
17 . A method of killing a microbe, comprising contacting the microbe with the cationic polymer of claim 13 .
18 . An antimicrobial composition, comprising the cationic polymer of claim 13 and a second component bound together by non-covalent interactions.
19 . The antimicrobial composition of claim 18 , wherein the second component is water.
20 . The antimicrobial composition of claim 18 , wherein the second component is an antibiotic drug.Join the waitlist — get patent alerts
Track US2017094964A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.